Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-12-03

Clinical Trial Update: Improving MEDication Adherence in Chronic Heart Failure Using a TELEmedicine Device (TELEMED-HF) [NA]

View source ↗

Summary

The TELEMED-HF trial evaluating a telemedicine device to improve medication adherence in chronic heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tilburg University | Conditions: Heart Failure | NA | Status: WITHDRAWN